Fund HoldingsLynx1 Capital Management LP

Total Portfolio Value
$151.19M
Total Bought
$17.86M
Total Sold
$31.27M
Net Transaction
-$13.41M
Filing Period:
Securities
SharesValue ($K)
Q2 2023
Q3 2023
Change
Q2 2023
Q3 2023
Weight (%)
Change
STOKE THERAPEUTICS INC(STOK)01,710,154+1,710,15406,7384.46%+6,738
CABALETTA BIO INC2,181,3772,106,000-75,37728,16232,05321.20%+3,892
AUTOLUS THERAPEUTICS PLC01,363,025+1,363,02503,1762.10%+3,176
SILENCE THERAPEUTICS PLC0235,787+235,78702,3151.53%+2,315
BIONOMICS LIMITED0815,512+815,51202,2021.46%+2,202
C4 THERAPEUTICS INC01,019,230+1,019,23001,8961.25%+1,896
CYMABAY THERAPEUTICS INC1,205,050994,161-210,88913,19514,8239.80%+1,628
PIERIS PHARMACEUTICALS INC9,775,8499,775,84901,6182,9131.93%+1,295
NEKTAR THERAPEUTICS(NKTR)01,766,815+1,766,81501,0520.70%+1,052
TSCAN THERAPEUTICS INC5,224,6005,224,600013,06213,3758.85%+313
ALPINE IMMUNE SCIENCES INC2,670,4722,404,614-265,85827,45227,53318.21%+80
ZURA BIO LTD09,917+9,9170650.04%+65
DBV TECHNOLOGIES S A18,26518,265035250.02%-10
COMPASS PATHWAYS PLC(CMPS)20,1140-20,1141670-167
PHARVARIS N V
COM
21,2250-21,2253210-321
GH RESEARCH PLC(GHRS)969,3741,103,178+133,80411,50211,0877.33%-415
ATHIRA PHARMA INC193,5730-193,5735710-571
STRUCTURE THERAPEUTICS INC23,0000-23,0009560-956
PASSAGE BIO INC1,167,343190,124-977,2191,0991250.08%-974
CULLINAN ONCOLOGY INC115,0630-115,0631,2380-1,238
NEOLEUKIN THERAPEUTICS INC3,094,5540-3,094,5542,5680-2,568
MERUS N V1,152,5251,150,225-2,30030,34627,12217.94%-3,224
KINNATE BIOPHARMA INC2,048,7361,997,006-51,7306,2082,7961.85%-3,412
THESEUS PHARMACEUTICALS INC757,009702,415-54,5947,0631,8891.25%-5,173
PARDES BIOSCIENCES INC3,902,4340-3,902,4347,0630-7,063
Page 1 of 1